| RS376162589 |
TOP2B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376163010 |
ETV6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS376163184 |
ARHGAP6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376163622 |
TTC21B
|
Health Risk |
Conflicting classifications of pathogenicity |
Jeune thoracic dystrophy, Nephronophthisis |
| RS376163818 |
F10
|
Health Risk |
Pathogenic |
Hereditary factor X deficiency disease, Hereditary factor X deficiency disease |
| RS376164225 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, 6 conditions |
| RS376164426 |
WDPCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 15, Bardet-Biedl syndrome |
| RS376164700 |
DNAAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS376165374 |
HPS6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 6, Hermansky-Pudlak syndrome 6 |
| RS376166098 |
ATXN7
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS376168781 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS376169369 |
TUFM
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376169815 |
ENG
|
Health Risk |
Conflicting classifications of pathogenicity |
Telangiectasia, hereditary hemorrhagic |
| RS3761702 |
MERTK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS376170264 |
SKIC3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376170600 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS376170776 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS376170815 |
COG7
|
Health Risk |
Conflicting classifications of pathogenicity |
COG7 congenital disorder of glycosylation, Inborn genetic diseases |
| RS376171095 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Ehlers-Danlos syndrome |
| RS376171433 |
SUCLG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 9, Mitochondrial DNA depletion syndrome 9 |
| RS376173303 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital glycogen storage disease of heart, Cardiomyopathy |
| RS376173313 |
NFATC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376174484 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS376174565 |
EEF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian serous cystadenocarcinoma, Ovarian serous cystadenocarcinoma |
| RS376174896 |
PRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4F, Charcot-Marie-Tooth disease type 4 |
| RS376175156 |
UPF3B
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability 14, UPF3B-related disorder |
| RS376176332 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS376177219 |
BRAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal-onset encephalopathy with rigidity and seizures, Inborn genetic diseases |
| RS376177973 |
HARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Perrault syndrome 2, Perrault syndrome |
| RS376178701 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS376179264 |
COL17A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS376179903 |
BRAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal-onset encephalopathy with rigidity and seizures, Inborn genetic diseases |
| RS376180339 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome |
| RS376181876 |
HARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Perrault syndrome 2, Gastric cancer |
| RS376183960 |
LMBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376185352 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS376185703 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS376186141 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal acantholytic epidermolysis bullosa, Arrhythmogenic right ventricular dysplasia 8 |
| RS376187378 |
COL18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Knobloch syndrome, Knobloch syndrome |
| RS376187918 |
SLC19A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS376188585 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS376188691 |
PRLR
|
Health Risk |
Pathogenic |
Familial hyperprolactinemia, Familial hyperprolactinemia |
| RS376188702 |
DYNC2H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Asphyxiating thoracic dystrophy 3, Jeune thoracic dystrophy |
| RS376188859 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Myopathy, myofibrillar |
| RS376189614 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS376189812 |
TBX3
|
Health Risk |
Conflicting classifications of pathogenicity |
Ulnar-mammary syndrome, TBX3-related disorder |
| RS376189927 |
IFT27
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 19, Inborn genetic diseases |
| RS376190109 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal Kniest-like syndrome, Schwartz-Jampel syndrome |
| RS376193228 |
KRT83
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376193847 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS376194507 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Congenital contractural arachnodactyly |
| RS376194706 |
CAMTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS376194840 |
RBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, RBP3-related disorder |
| RS376194864 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, NEB-related disorder |
| RS376195897 |
CRPPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS376196220 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS376196793 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS376197467 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS376197674 |
USH1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1C, Usher syndrome type 1C |
| RS376198104 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS376198840 |
PROM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal macular dystrophy type 2, Stargardt disease 4 |
| RS376199241 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS376200169 |
TG
|
Health Risk |
Likely pathogenic |
Congenital hypothyroidism, Iodotyrosyl coupling defect |
| RS376201065 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS376201066 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS376201106 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376202643 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS376206840 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS376206979 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hyperinsulinism, Maturity-onset diabetes of the young |
| RS376207235 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS376207606 |
HSD3B2
|
Health Risk |
Conflicting classifications of pathogenicity |
3 beta-Hydroxysteroid dehydrogenase deficiency, 3 beta-Hydroxysteroid dehydrogenase deficiency |
| RS376208076 |
MYH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Distal arthrogryposis type 2B1, Freeman-Sheldon syndrome |
| RS376208769 |
TRDN
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 5, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS376209388 |
AIFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth Neuropathy X, Combined oxidative phosphorylation deficiency |
| RS376210355 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS376210604 |
HLCS
|
Health Risk |
Conflicting classifications of pathogenicity |
Holocarboxylase synthetase deficiency, Inborn genetic diseases |
| RS376211703 |
PRKDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to DNA-PKcs deficiency, Severe combined immunodeficiency due to DNA-PKcs deficiency |
| RS376212738 |
CYP27B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin D-dependent rickets, type 1 |
| RS376213437 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS376213990 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS376215289 |
PIK3R2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome |
| RS376215728 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Danon disease, Cardiovascular phenotype |
| RS376216286 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCB11-related disorder, Benign recurrent intrahepatic cholestasis type 2 |
| RS376216833 |
CTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, Inborn genetic diseases |
| RS376217891 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS376218204 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS376219481 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS376219601 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS376220034 |
NHP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal recessive 2 |
| RS376220212 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS376220834 |
DIAPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome, Autosomal dominant nonsyndromic hearing loss 1 |
| RS376221105 |
ALPL
|
Health Risk |
Pathogenic |
— |
| RS376222034 |
CCDC50
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376222605 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS376222680 |
SYP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS376223052 |
AARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 8, Combined oxidative phosphorylation defect type 8 |
| RS376223781 |
ASH1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Autism spectrum disorder, ASH1L-related disorder |
| RS376223981 |
ADSS1
|
Health Risk |
Likely pathogenic |
Ovarian serous cystadenocarcinoma, Acute myeloid leukemia |
| RS376225163 |
TEK
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple cutaneous and mucosal venous malformations, TEK-related disorder |
| RS376225756 |
CDK5RAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 3, primary |